Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3...
TOWNPLACE, the Largest Serviced Apartment Brand under Sun Hung Kai Properties
Curating Hong Kong's Finest Pet-Friendly Experience with Privileged Social Spaces Redefining Sophisticated Living for the Elite Exclusive Welcome Privileges for the Elite Pet Families HONG KONG, June 25, 2025 /PRNewswire/ -- As Hong Kong's public...
HanchorBio Presents Promising Data on HCB101 Checkpoint Inhibitor Immunotherapy at ASCO
Interim data on the cancer treatment shows robust potential for balancing efficacy and safety TAIPEI and SHANGHAI and SAN FRANCISCO, June 17, 2025 /PRNewswire/ -- Following a successful launch of Phase 2 clinical trials in March, HanchorBio Inc., a...
TGE Presents the Year's Highly-Anticipated Suspense Thriller Movie: "She's Got No Name"
NEW YORK, PARIS and SINGAPORE, June 12, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD" or the "Group"), alongside The Generation Essentials Group (NYSE: TGE), a subsidiary of the Group under AMTD Digital (NYSE: HKD), jointly announced that AMTD's...
Jackery Presents Latest Sustainable Energy Solutions at AIA25 Expo
BOSTON, June 9, 2025 /PRNewswire/ -- Jackery, a global leader in innovative solar generators and renewable energy solutions, showcased its latest breakthroughs at the AIA25 Expo held in Boston from June 5–6. Featuring its new Essential Home Backup...
Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association
EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN) and other autoimmune renal diseases, including IgA nephropathy (IgAN), minimal change disease...
